Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 


Akt inhibitor
BML-EI336-0010 10 mg 88.00 USD
BML-EI336-0050 50 mg 292.00 USD
Do you need bulk/larger quantities?
Inhibits the translocation of Akt.

Product Details

Purity:≥98% (TLC)
Identity:Determined by 1H-NMR.
Appearance:Light green solid.
Solubility:Soluble in DMSO (25 mg/ml).
Long Term Storage:Ambient
Regulatory Status:RUO - Research Use Only
Please mouse over

Product Literature References

Stereospecific inhibition of AMPK by (R)-crizotinib induced changes to the morphology and properties of cancer and cancer stem cell-like cells: T.H. Kim, et al.; Eur. J. Pharmacol. 911, 174525 (2021), Abstract;
Pharmacological inhibition of mTORC1 increases CCKBR-specific tumor uptake of radiolabeled minigastrin analogue [ 177 Lu]Lu-PP-F11N: M. Grzmil, et al.; Theranostics 10, 10861 (2020), Abstract; Full Text
Systems kinomics demonstrates Congo Basin monkeypox virus infection selectively modulates host cell signaling responses as compared to West African monkeypox virus: J. Kindrachuk, et al.; Mol. Cell. Proteomics 11, M111.015701 (2012), Application(s): Cell Culture, Abstract; Full Text
Identification of Akt pathway inhibitors using redistribution screening on the FLIPR and the IN Cell 3000 analyzer: B.K. Lundholt, et al.; J. Biomol. Screen. 10, 20 (2005), Abstract;

Related Literature

Essential Research Tools for Neurodegeneration & Neural Signaling
Essential Research Tools for Neurodegeneration & Neural Signaling
Download as PDF

All new literature pieces

Keep in touch

©2022 Enzo Life Sciences, Inc.,